4/8/2013 9:43:20 AM
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTC:SNTI) today announced that Leslie J. Browne, Ph.D., the Company’s President and Chief Executive Officer, is being treated for a medical condition that may limit his time to travel and attend public events. However, Dr. Browne will continue with his day-to-day duties and responsibilities as President and CEO of the Company. The Senesco Board has agreed to assist Dr. Browne with certain activities, including Harlan Waksal, M.D., Chairman of Senesco, who will take the lead on certain public activities like investor relations. The Board will continue to monitor Dr. Browne’s responsibilities as his treatment progresses.
comments powered by